Department of Cancer Control and Statistics
Last update May 2, 2008
Osaka Cancer Registry
This web site shows outlines, major objectives, and organization of the Osaka Cancer Registry. Recent cancer incidence and survival data in Osaka are summarized and over viewed, together with their time-trends.
Outlines
Osaka Cancer Registry (OCR) has been operating since December 1962 and has accumulated about 912 thousand cancer incidence data in Osaka prefecture (April 2008). Its population was 8.8 million in 2005 census. Ninety-seven % of them were Japanese, 1.3% or 114 thousands were Koreans, and 0.3% or 26 thousands were Chinese. Cancer incidence data in Osaka have been reported in Cancer Incidence in Five Continents through volume II - IX. Quality of the data meets a standard level by IACR during recent more than 40 years.
Major object

(1)To estimate incidence rates in Osaka.
(2)To compute statistics on medical treatment conducted for cancer patients in Osaka.
(3)To estimate cancer patient survival.

(4)To assist planning and evaluation of cancer control programs.

(5)To distribute cancer statistics and other information produced at the Registry to the participating
　　medical institutions and health administrators in Osaka to assist and promote their cancer control
　　activities.

(6)To promote the utilization of registry data for epidemiological and clinical studies.
Organization
The Osaka Prefectural Department of Public Health and Welfare has been responsible for budgetary support of the registration scheme, collecting cancer death information from health centers, and surveying prognosis of registered cancer cases by the method of referring to inhabitant registers in local municipality offices.
The Osaka Medical Association (OMA) requests all medical institutions located in the Prefecture to cooperate with cancer registration on a voluntary basis. The OMA encourages hospital doctors and general practitioners to prepare cancer reports when they treat cancer cases and to send the reports to the OMA. The OMA is also responsible for promoting the distribution of cancer information from the Registry to participating institutions and medical doctors concerned.
The OCR was set up at the Department of Cancer Control and Statistics (the Director, Hideaki Tsukuma, MD, PhD), the Osaka Medical Center for Cancer and Cardiovascular Diseases, as a central registry responsible for all registry work.
Numbers of incidence, crude incidence rates and age-standardized incidence rates
(per 100,000) by primary site and gender in Osaka, 2004
ICD-10 Numbers of incidence Proportion (%) Crude rates Age-standardized rates*
Male Female Total Male Female Male Female Male Female
All sites C00-C96 19,330 13,585 32,915 100.0 100.0 451.1 299.9 225.4 140.9
Esophagus C15 873 182 1,055 4.5 1.4 20.4 4.0 10.4 1.8
Stomach C16 3,857 1,783 5,640 19.5 13.1 90.0 39.4 44.4 16.3
Colon C18 1,842 1,564 3,406 9.4 11.6 43.0 34.5 21.2 13.9
Rectum C19-C21 1,064 553 1,617 5.5 4.3 24.8 12.2 12.8 5.4
Liver C22 2,250 1,039 3,289 12.5 8.0 52.5 22.9 25.3 8.2
Gallbladder C23-C24 444 485 929 2.3 3.7 10.4 10.7 4.8 3.6
Pancreas C25 804 723 1,527 4.0 4.8 18.8 16.0 9.2 5.9
Lung C33-C34 3,620 1,478 5,098 18.4 11.0 84.5 32.6 39.8 12.8
Breast C50 11 2,365 2,376 0.1 17.2 0.3 52.2 0.1 32.9
Uterus (1) C53-C55, D06 ･ 1,066 1,066 ･ 7.4 ･ 23.5 ･ 14.8
Uterus (2) C53-C55 ･ 865 865 ･ 6.1 ･ 19.1 ･ 11.1
Ovary C56 ･ 405 405 ･ 2.9 ･ 8.9 ･ 5.4
Prostate C61 1,153 ･ 1,153 5.9 ･ 26.9 ･ 13.2 ･
Bladder C67 575 177 752 3.1 1.3 13.4 3.9 6.4 1.3
Lymphatic tissue C81-C90, C96 529 421 950 2.9 3.3 12.3 9.3 6.5 4.2
Leukemia C91-C95 316 235 551 1.7 1.7 7.4 5.2 5.6 4.3
"Uterus (1)" includes "In situ cervix uteri", while "Uterus (2)" does not.
"All sites" do not include "In situ cervix uteri" and "In situ breast".
* Standardized to World population.

Time-trends of age-standardized incidence rates (world population, per 100,000) by primary site and gender in Osaka during the periods between 1966 and 2004
Time-trends of age-standardized incidence rates (1985 Japanese standard population, per 100,000) by primary site and gender in Osaka during the periods between 1966 and 2004
Relative 5-year survival of patients diagnosed in Osaka (include Osaka City) 1996-98 according to primary site
Sites ICD-10 No. of study subjects Relative 5-year survival (%) S.E.(%)
Male Female Total Male Female Total Male Female Total
All sites C00-C96 39,700 29,193 68,893 38.0 50.5 43.5 0.2 0.3 0.2
Lip, oral cavity and pharynx C00-C08 587 333 920 55.6 72.2 61.7 2.1 2.6 1.6
Esophagus C15 1,694 332 2,026 19.9 23.4 20.4 0.9 2.2 0.9
Stomach C16 8,926 4,343 13,269 50.9 48.6 50.2 0.5 0.8 0.4
Colon C18 3,320 2,881 6,201 58.2 54.3 56.3 0.9 0.9 0.6
Rectum C19-C21 2,304 1,285 3,589 53.7 53.3 53.5 1.0 1.4 0.8
Liver C22 6,016 2,206 8,222 19.3 18.0 19.0 0.5 0.8 0.4
Gallbladder C23-C24 819 1,039 1,858 15.2 13.9 14.5 1.1 1.0 0.8
Pancreas C25 1,271 1,017 2,288 5.6 5.5 5.5 0.6 0.7 0.4
Larynx C32 461 33 494 72.7 57.3 71.6 2.3 8.7 2.2
Lung C33-C34 6,542 2,618 9,160 15.2 20.6 16.8 0.4 0.8 0.4
Breast C50 30 5,815 5,845 97.2 80.9 81.0 6.8 0.5 0.5
Uterus C53-C55 ･ 2,007 2,007 ･ 66.4 66.4 ･ 1.1 1.1
Ovary C56 ･ 895 895 ･ 39.3 39.3 ･ 1.6 1.6
Prostate C61 1,502 ･ 1,502 67.3 ･ 67.3 1.3 ･ 1.3
Bladder C67 1,067 305 1,372 72.6 61.6 70.1 1.5 2.9 1.3
Kidney C64-C66,C68 837 374 1,211 56.4 59.9 57.5 1.7 2.6 1.4
Brain C71 225 222 447 31.1 36.3 33.7 3.0 3.2 2.2
Thyroid gland C73 172 673 845 85.3 87.8 87.3 3.2 1.5 1.3
Lymphatic tissue C81-C90,C96 1,167 831 1,998 36.3 41.8 38.6 1.4 1.7 1.1
Leukemia C91-C95 669 525 1,194 25.8 30.7 28.0 1.6 2.0 1.3
"Uterus" does not includes "In situ cervix uteri".

Time-trends of relative 5-year survival of patients diagnosed in Osaka (exclude Osaka City)
References

1. Tanaka H, et al. Declining incidence of hepatocellular carcinoma in Osaka, Japan, from 1990 to 2003. Ann Int Med (2008) 148: 820-826.

2. Tabata N, et al. Partial cancer prevalence in Japan up to 2020: Estimates based on incidence and survival data from population-based cancer registries. Jpn J Clin Oncol (2008) 38: 146-157.

3. Ioka A, et al. Hospital procedure volume and survival of cancer patients in Osaka, Japan: a population-based study with latest cases. Jpn J Clin Oncol (2007) 37: 544-553.

4. Ito Y, et al. Cancer survival trends in Osaka, Japan: the influence of age and stage at diagnosis. Jpn J Clin Oncol (2007) 37: 452-458.

5. Saika K, et al. The trend of the effect of surgical volume up to 5 years after resection for stomach and lung cancer patients. Jpn J Applied IT Healthcare (2007) 1: 42-49.

6. Matsuno R, et al. Early- and late-onset breast cancer types among women in theUnited States and Japan. Cancer Epidemiol Biomarkers Prev (2007) 16: 1437–42.

7. Tanaka H, et al. Distinctive change in male liver cancer incidence rate between the 1970s and 1990s in Japan: comparison with Japanese-American and US whites. Jpn J Clin Oncol (2007) 37: 193-196.

8. Kanazawa N, et al. Incidence and survival of mesothelioma in Osaka, Japan. Jpn J Clin Oncol (2006) 36: 254-257.

9. Nomura E, et al. Population-based study of relationship between the hospital surgical volume and the 10-year survival of breast cancer patients in Osaka, Japan. Cancer Science (2006) 97: 618-622.

10. Ueda K, et al. Cervical and corpus cancer survival disparities by socioeconomic status in a metropolitan area of Japan. Cancer Science (2005) 97: 283-291.

11. Ueda K, et al. Socioeconomic factors and cancer incidence, mortality, and survival in a metropolitan area of Japan: A cross-sectional ecological study. Cancer Science (2005) 96: 684-688.

12. Ioka A, et al. Influence of hospital procedure volume on uterine cancer survival in Osaka, Japan. Cancer Science (2005) 96: 689-694.

13. Ioka A, et al. Trends in head and neck cancer incidence in Japan during 1965-1999. Jpn J Clin Oncol (2005) 35: 45-47.

14. Ioka A, et al. Influence of age on cervical cancer survival in Japan. Jpn J Clinic Oncol (2005) 35: 464-469.

15. Tsukuma H, et al. Liver cancer and its prevention. Asian Pacific Journal of Cancer Prevention (2005) 6: 1-7.

16. Kitamura Y, et al. Statistical estimation of the number of breast cancer patients with disabilities resulting from surgery. Breast Cancer (2005) 12: 130-134.

17. AjikiW, et al. Cancer incidence rates in Jpan in 1999: Estimates based on data from 11 population-based cancer registries. Jpn J Clim Oncol (2004) 34: 352-356.

18. Ajiki W, et al. Survival rates of childhood cancer patients in Osaka, Japan. Jpn J Clin Oncol (2004) 34:50-54.

19. Ioka A, et al. Influence of hospital procedure volume on ovarian cancer survival in Japan, a country with low incidence of ovarian cancer. Cancer Sci (2004) 95: 233-237.

20. Tsukuma H, et al. Cancer Incidence in Japan. Cancer Mortality and Morbidity Statistics: Japan and the World-2004, Tajima K, Kuroishi T, Oshima A (ed), Gann Monograph on Cancer Research (2004) No. 51: 95-130, Japan Sci Soc Press, Tokyo.

21. Ajiki W, et al. Trends in cancer incidence and survival in Osaka. Cancer Mortality and Morbidity Statistics: Japan and the World-2004, Tajima K, Kuroishi T, Oshima A (ed), Gann Monograph on Cancer Research (2004) No. 51: 137-163. Japan Sci Soc Press, Tokyo.

22. Ioka A, et al. Ovarian cancer incidence and survival by histologic type in Osaka, Japan. Cancer Sci (2003) 94: 292-296.

23. Honjo S, et al. Neuroblastoma trends in Osaka, Japan, and Great Britain 1970-1994, in relation to screening. Int J Cancer (2003) 103: 538-43.

24. Yoshimi I, et al. A comparison of trends in the incidence of lung cancer by histological type in the Osaka cancer Registry, Japan and in the Surveillance, Epidemiology and End Results Program, USA. Jpn J Clin Oncol (2003) 33: 98-104.

25. Ueda K, et al. Estimation of individualized probabilities of developing breast cancer for Japanese women. Breast Cancer (2003) 10: 54-62.

26. Nomura E, et al. Population-based study of relationship between hospital surgical volume and 5-year survival of stomach cancer patients in Osaka, Japan. Cancer Sci (2003) 94:998-1002.

27. Ioka A, et al. Trends of uterine cancer incidence in Japan in 1975-1998. Jpn J Clin Oncol (2003) 33: 645-646.

28. Verdecchia A, et al. Comparison of stomach cancer incidence and survival in four continents. Eur J Cancer (2003) 39: 1603-1609.

29. Lambert R, et al. Incidence and mortality from stomach cancer in Japan, Slovenia and the USA. Int J Cancer (2002) 97: 811-8.